RecruitingNCT01772771

Molecular Testing for the MD Anderson Cancer Center Personalized Cancer Therapy Program

Sponsor

M.D. Anderson Cancer Center

Enrollment

12,000 participants

Start Date

Mar 1, 2012

Study Type

OBSERVATIONAL

Conditions

Malignant Solid Neoplasm Sarcoma Melanoma Hematopoietic and Lymphoid Cell Neoplasm Glioma

Summary

This study performs standardized testing of tumor tissue samples to learn which genes are mutated (have changed) in order to provide personalized cancer therapy options to cancer patients at MD Anderson. This may help doctors use testing information on tumors to identify clinical trials that may be most relevant to patients. Researchers may also use the information learned from this study to develop a database of the different kinds of mutations in cancer-related genes.

Eligibility

Plain Language Summary

Simplified for easier understanding

This program at MD Anderson Cancer Center performs detailed genetic and molecular testing on cancer tumors to help doctors personalize treatment plans for patients with many types of cancer. **You may be eligible if...** - You have been diagnosed with virtually any type of cancer — including solid tumors, blood cancers, brain tumors, sarcomas, or melanoma - You are willing to have your tumor tissue or a blood sample tested - You are able to give written consent **You may NOT be eligible if...** - There is no tissue or blood sample available for testing Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.